1 Min Read
April 3 (Reuters) - Interpace Diagnostics Group Inc
* Interpace Diagnostics Group Inc- on March 31 entered into a waiver agreement of company's senior secured convertible note - SEC filing Source: (bit.ly/2oAPoce) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.